Idarucizumab for reversal of dabigatran etexilate-induced gastrointestinal bleeding

Lin Qi, Dong Shujie, Li Lei, Wang Kun, Shi Junbao, Yang Li

PDF(345 KB)
PDF(345 KB)
Adverse Drug Reactions Journal ›› 2025, Vol. 27 ›› Issue (1) : 53-55. DOI: 10.3760/cma.j.cn114015-20240304-00129

Idarucizumab for reversal of dabigatran etexilate-induced gastrointestinal bleeding

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 27(1): 53-55 https://doi.org/10.3760/cma.j.cn114015-20240304-00129

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(345 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉